Terms: = Bone cancer AND NCOR2, SMRTE-tau, 9612, ENSG00000196498, SMRTE, TNRC14, TRAC-1, SMRT, CTG26, TRAC1
16 results:
1. Xanthogranulomatous Epithelial Tumors and Keratin-Positive Giant Cell Rich Tumors of Soft Tissue and bone: Two Sides of the Same Coin.
Folpe AL
Surg Pathol Clin; 2024 Mar; 17(1):57-64. PubMed ID: 38278607
[TBL] [Abstract] [Full Text] [Related]
2. Keratin-positive giant cell-rich tumors of soft tissue with HMGA2::ncor2 fusions.
Weigelt MA; Azzato EM; Habermehl GK; Billings SD; Ko JS; Fritchie KJ
J Cutan Pathol; 2023 Nov; 50(11):977-982. PubMed ID: 37496152
[TBL] [Abstract] [Full Text] [Related]
3. Keratin-Positive Giant Cell-Rich Tumor of bone Harboring an
Patton A; Ilaslan H; Armstrong SM; Bakhshwin A; Cheng YW; Minhas F; Fritchie KJ
Int J Surg Pathol; 2024 May; 32(3):556-564. PubMed ID: 37461232
[TBL] [Abstract] [Full Text] [Related]
4. Giant Cell Tumors With HMGA2::ncor2 Fusion : Clinicopathologic, Molecular, and Epigenetic Study of a Distinct Entity.
Perret R; Malaka Z; Velasco V; Llamas-Gutierrez F; Ropars M; Linck PA; Hostein I; Azmani R; Valo I; Galmiche L; Moreau A; de Pinieux G; Michot A; Bochaton D; Coindre JM; Le Loarer F
Am J Surg Pathol; 2023 Jul; 47(7):801-811. PubMed ID: 37170907
[TBL] [Abstract] [Full Text] [Related]
5. bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas.
Fanburg-Smith JC; Smith JD; Flemming DJ
Skeletal Radiol; 2023 Mar; 52(3):517-540. PubMed ID: 36542130
[TBL] [Abstract] [Full Text] [Related]
6. Recurrent Fusion of the Genes for High-mobility Group AT-hook 2 (
Panagopoulos I; Andersen K; Gorunova L; Lund-Iversen M; Lobmaier I; Heim S
Cancer Genomics Proteomics; 2022; 19(2):163-177. PubMed ID: 35181586
[TBL] [Abstract] [Full Text] [Related]
7. Molecular classification of a complex structural rearrangement of the RB1 locus in an infant with sporadic, isolated, intracranial, sellar region retinoblastoma.
Schieffer KM; Feldman AZ; Kautto EA; McGrath S; Miller AR; Hernandez-Gonzalez ME; LaHaye S; Miller KE; Koboldt DC; Brennan P; Kelly B; Wetzel A; Agarwal V; Shatara M; Conley S; Rodriguez DP; Abu-Arja R; Shaikhkhalil A; Snuderl M; Orr BA; Finlay JL; Osorio DS; Drapeau AI; Leonard JR; Pierson CR; White P; Magrini V; Mardis ER; Wilson RK; Cottrell CE; Boué DR
Acta Neuropathol Commun; 2021 Apr; 9(1):61. PubMed ID: 33827698
[TBL] [Abstract] [Full Text] [Related]
8. Recurrent novel HMGA2-ncor2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors.
Agaimy A; Michal M; Stoehr R; Ferrazzi F; Fabian P; Michal M; Franchi A; Haller F; Folpe AL; Kösemehmetoğlu K
Mod Pathol; 2021 Aug; 34(8):1507-1520. PubMed ID: 33742141
[TBL] [Abstract] [Full Text] [Related]
9. A single-cell survey of cellular hierarchy in acute myeloid leukemia.
Wu J; Xiao Y; Sun J; Sun H; Chen H; Zhu Y; Fu H; Yu C; E W; Lai S; Ma L; Li J; Fei L; Jiang M; Wang J; Ye F; Wang R; Zhou Z; Zhang G; Zhang T; Ding Q; Wang Z; Hao S; Liu L; Zheng W; He J; Huang W; Wang Y; Xie J; Li T; Cheng T; Han X; Huang H; Guo G
J Hematol Oncol; 2020 Sep; 13(1):128. PubMed ID: 32977829
[TBL] [Abstract] [Full Text] [Related]
10. Single-Molecule Real-Time (smrt) Full-Length RNA-Sequencing Reveals Novel and Distinct mRNA Isoforms in Human bone Marrow Cell Subpopulations.
Deslattes Mays A; Schmidt M; Graham G; Tseng E; Baybayan P; Sebra R; Sanda M; Mazarati JB; Riegel A; Wellstein A
Genes (Basel); 2019 Mar; 10(4):. PubMed ID: 30934798
[TBL] [Abstract] [Full Text] [Related]
11. bone stroma-derived cells change coregulators recruitment to androgen receptor and decrease cell proliferation in androgen-sensitive and castration-resistant prostate cancer cells.
Villagran MA; Gutierrez-Castro FA; Pantoja DF; Alarcon JC; Fariña MA; Amigo RF; Muñoz-Godoy NA; Pinilla MG; Peña EA; Gonzalez-Chavarria I; Toledo JR; Rivas CI; Vera JC; McNerney EM; Onate SA
Biochem Biophys Res Commun; 2015 Nov; 467(4):1039-45. PubMed ID: 26494300
[TBL] [Abstract] [Full Text] [Related]
12. MicroRNAs are mediators of androgen action in prostate and muscle.
Narayanan R; Jiang J; Gusev Y; Jones A; Kearbey JD; Miller DD; Schmittgen TD; Dalton JT
PLoS One; 2010 Oct; 5(10):e13637. PubMed ID: 21048966
[TBL] [Abstract] [Full Text] [Related]
13. Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1.
Choi WI; Jeon BN; Yun CO; Kim PH; Kim SE; Choi KY; Kim SH; Hur MW
J Biol Chem; 2009 May; 284(19):12633-44. PubMed ID: 19244234
[TBL] [Abstract] [Full Text] [Related]
14. Structural basis for recognition of smrt/N-CoR by the MYND domain and its contribution to AML1/ETO's activity.
Liu Y; Chen W; Gaudet J; Cheney MD; Roudaia L; Cierpicki T; Klet RC; Hartman K; Laue TM; Speck NA; Bushweller JH
Cancer Cell; 2007 Jun; 11(6):483-97. PubMed ID: 17560331
[TBL] [Abstract] [Full Text] [Related]
15. A peptide aptamer to antagonize BCL-6 function.
Chattopadhyay A; Tate SA; Beswick RW; Wagner SD; Ko Ferrigno P
Oncogene; 2006 Apr; 25(15):2223-33. PubMed ID: 16331266
[TBL] [Abstract] [Full Text] [Related]
16. Transcriptional inactivation of STAT3 by PPARgamma suppresses IL-6-responsive multiple myeloma cells.
Wang LH; Yang XY; Zhang X; Huang J; Hou J; Li J; Xiong H; Mihalic K; Zhu H; Xiao W; Farrar WL
Immunity; 2004 Feb; 20(2):205-18. PubMed ID: 14975242
[TBL] [Abstract] [Full Text] [Related]
